This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Clark, C.
Right arrow Articles by Appelbaum, P. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, C.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2009, p. 3118-3121, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.00183-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Resistance Selection Studies Comparing the Activity of Razupenem (PTZ601) to Vancomycin and Linezolid against Eight Methicillin-Resistant and Two Methicillin-Susceptible Staphylococcus aureus Strains{triangledown}

Catherine Clark, Klaudia Kosowska-Shick, Pamela McGhee, Bonifacio Dewasse, Linda Beachel, and Peter C. Appelbaum*

Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033

Received 10 February 2009/ Returned for modification 5 April 2009/ Accepted 5 May 2009

Multistep and single-step resistance selection studies were performed with razupenem, linezolid, and vancomycin against 10 methicillin (meticillin)-resistant and -susceptible Staphylococcus aureus strains. After 20 daily subcultures, razupenem yielded only clones with MICs of >4 µg/ml in one strain (8 µg/ml) whose parent's MIC was already 4 µg/ml. After 18 to 49 passages in 6/10 strains, razupenem MICs rose from 0.016 to 2 µg/ml (parents) to 0.125 to 8 µg/ml (with clones stable after 10 drug-free subcultures). Single-step mutant selection frequencies were similarly low for razupenem and comparators.


* Corresponding author. Mailing address: Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psu.edu

{triangledown} Published ahead of print on 11 May 2009.


Antimicrobial Agents and Chemotherapy, July 2009, p. 3118-3121, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.00183-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.